Actively Recruiting

Phase Not Applicable
Age: 12Years - 18Years
All Genders
NCT07219810

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

Led by Bradley Hospital · Updated on 2025-10-22

50

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this project is to examine the differential therapeutic effect of intermittent theta burst stimulation (iTBS; a type of repetitive transcranial magnetic stimulation) to the left DLPFC versus right PreSMA in modulating working memory (WM) versus inhibitory control (IC) deficits. Fifty adolescents (12-18 years old) with parent-reported WM and IC deficits and diagnosed ADHD will be randomized to DLPFC or PreSMA targeted 3x-daily iTBS for a total of ten days (30 total sessions).

CONDITIONS

Official Title

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

Who Can Participate

Age: 12Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 12-18 years
  • Participant and parent are fluent in English and able to provide informed consent/assent
  • Clinical diagnosis of ADHD confirmed by diagnostic interview
  • Parent rating on BRIEF-2 showing working memory and inhibition scale T-Scores greater than 60
  • IQ greater than 70
Not Eligible

You will not qualify if you...

  • Intracranial pathology from genetic or acquired neurologic disorders, cerebral palsy, severe head injury, or significant dysmorphology
  • History of fainting spells of unknown cause possibly related to seizures
  • History of seizures, epilepsy diagnosis, or immediate family history of epilepsy
  • Progressive neurological disorders
  • Uncontrolled chronic medical conditions that may cause emergencies if seizures occur
  • Contraindicated metal implants in head, brain, or spinal cord (excluding dental implants/fillings)
  • Non-removable makeup or piercings
  • Presence of pacemaker, implanted medication pump, or ventriculo-peritoneal shunt
  • Use of vagal nerve stimulator, deep brain stimulator, or transcutaneous electrical nerve stimulation
  • Signs of increased intracranial pressure or intracranial lesions
  • History of head injury causing prolonged loss of consciousness
  • Substance abuse or dependence within past six months
  • Chronic use of medications lowering seizure threshold, excluding medically safe psychostimulants
  • Active psychosis or mania
  • Acute suicidal intent
  • Current pregnancy
  • Significant visual, hearing, or speech impairments
  • Presence of dental braces
  • Current wards of the state

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

E. P. Bradley Hospital

East Providence, Rhode Island, United States, 02915

Actively Recruiting

Loading map...

Research Team

B

Brian K Kavanaugh, PsyD; PI, PsyD ABPP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here